Literature DB >> 25979093

Altered Sleep Stage Transitions of REM Sleep: A Novel and Stable Biomarker of Narcolepsy.

Yaping Liu1, Jihui Zhang1, Venny Lam1, Crover Kwok Wah Ho1, Junying Zhou1,2, Shirley Xin Li1, Siu Ping Lam1, Mandy Wai Man Yu1, Xiangdong Tang2, Yun-Kwok Wing1.   

Abstract

OBJECTIVES: To determine the diagnostic values, longitudinal stability, and HLA association of the sleep stage transitions in narcolepsy.
METHODS: To compare the baseline differences in the sleep stage transition to REM sleep among 35 patients with type 1 narcolepsy, 39 patients with type 2 narcolepsy, 26 unaffected relatives, and 159 non-narcoleptic sleep patient controls, followed by a reassessment at a mean duration of 37.4 months.
RESULTS: The highest prevalence of altered transition from stage non-N2/N3 to stage R in multiple sleep latency test (MSLT) and nocturnal polysomnography (NPSG) was found in patients with type 1 narcolepsy (92.0% and 57.1%), followed by patients with type 2 narcolepsy (69.4% and 12.8%), unaffected relatives (46.2% and 0%), and controls (39.3% and 1.3%). Individual sleep variables had varied sensitivity and specificity in diagnosing narcolepsy. By incorporating a combination of sleep variables, the decision tree analysis improved the sensitivity to 94.3% and 82.1% and enhanced specificity to 82.4% and 83% for the diagnosis of type 1 and type 2 narcolepsy, respectively. There was a significant association of DBQ1*0602 with the altered sleep stage transition (OR = 16.0, 95% CI: 1.7-149.8, p = 0.015). The persistence of the altered sleep stage transition in both MSLT and NPSG was high for both type 1 (90.5% and 64.7%) and type 2 narcolepsy (92.3% and 100%), respectively.
CONCLUSION: Altered sleep stage transition is a significant and stable marker of narcolepsy, which suggests a vulnerable wake-sleep dysregulation trait in narcolepsy. Altered sleep stage transition has a significant diagnostic value in the differential diagnosis of hypersomnias, especially when combined with other diagnostic sleep variables in decision tree analysis.
© 2015 American Academy of Sleep Medicine.

Entities:  

Keywords:  biomarker; hypersomnia; multiple sleep latency test; narcolepsy; sleep onset REM sleep period; sleep stage transitions

Mesh:

Substances:

Year:  2015        PMID: 25979093      PMCID: PMC4513266          DOI: 10.5664/jcsm.4940

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  30 in total

1.  Elicitation of sleep-onset REM periods in normal individuals using the sleep interruption technique (SIT).

Authors:  Tomoka Takeuchi; Kazuhiko Fukuda; Timothy I Murphy
Journal:  Sleep Med       Date:  2002-11       Impact factor: 3.492

2.  Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy.

Authors:  M S Aldrich; R D Chervin; B A Malow
Journal:  Sleep       Date:  1997-08       Impact factor: 5.849

Review 3.  Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination.

Authors:  Markku Partinen; Birgitte Rahbek Kornum; Giuseppe Plazzi; Poul Jennum; Ilkka Julkunen; Outi Vaarala
Journal:  Lancet Neurol       Date:  2014-06       Impact factor: 44.182

4.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

5.  Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness.

Authors:  M A Carskadon; W C Dement; M M Mitler; T Roth; P R Westbrook; S Keenan
Journal:  Sleep       Date:  1986-12       Impact factor: 5.849

Review 6.  Comparing MSLT and ESS in the measurement of excessive daytime sleepiness in obstructive sleep apnoea syndrome.

Authors:  S Y Y Fong; C K W Ho; Y K Wing
Journal:  J Psychosom Res       Date:  2005-01       Impact factor: 3.006

7.  HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.

Authors:  E Mignot; R Hayduk; J Black; F C Grumet; C Guilleminault
Journal:  Sleep       Date:  1997-11       Impact factor: 5.849

8.  The prevalence of narcolepsy among Chinese in Hong Kong.

Authors:  Yun-Kwok Wing; Raymond Hiu-Yeung Li; Ching-Wan Lam; Crover Kwok-Wah Ho; Samson Yuk-Yat Fong; Tony Leung
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

9.  The familial risk and HLA susceptibility among narcolepsy patients in Hong Kong Chinese.

Authors:  Lei Chen; S Y Y Fong; Ching W Lam; Nelson L S Tang; Margaret H L Ng; Albert M Li; C K W Ho; Suk-Hang Cheng; Kin-Mang Lau; Yun Kwok Wing
Journal:  Sleep       Date:  2007-07       Impact factor: 5.849

10.  Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.

Authors:  Olivier Andlauer; Hyatt Moore; Laura Jouhier; Christopher Drake; Paul E Peppard; Fang Han; Seung-Chul Hong; Francesca Poli; Giuseppe Plazzi; Ruth O'Hara; Emmanuel Haffen; Thomas Roth; Terry Young; Emmanuel Mignot
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

View more
  4 in total

1.  A false alarm of narcolepsy: obstructive sleep apnea masquerading as narcolepsy and vice-versa: two further controversial cases.

Authors:  A Romigi; M Caccamo; G Vitrani; F Testa; C Nicoletta; A C Sarno; B Di Gioia; D Centonze
Journal:  Sleep Breath       Date:  2020-04-15       Impact factor: 2.816

2.  Differential characteristics of repeated polysomnography and multiple sleep latency test parameters in narcolepsy type 1 and type 2 patients: a longitudinal retrospective study.

Authors:  Yoo Hyun Um; Jihye Oh; Sung-Min Kim; Tae-Won Kim; Ho-Jun Seo; Jong-Hyun Jeong; Seung-Chul Hong
Journal:  Sleep Breath       Date:  2021-11-25       Impact factor: 2.816

3.  A false alarm of narcolepsy: obstructive sleep apnea masquerading as narcolepsy and depression.

Authors:  Dhirendra Paudel; Qiuyan Lin; Caiping Yan; Shuai Liu; Bin Zhang
Journal:  Sleep Breath       Date:  2018-12-06       Impact factor: 2.655

4.  Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy.

Authors:  Jens B Stephansen; Alexander N Olesen; Mads Olsen; Aditya Ambati; Eileen B Leary; Hyatt E Moore; Oscar Carrillo; Ling Lin; Fang Han; Han Yan; Yun L Sun; Yves Dauvilliers; Sabine Scholz; Lucie Barateau; Birgit Hogl; Ambra Stefani; Seung Chul Hong; Tae Won Kim; Fabio Pizza; Giuseppe Plazzi; Stefano Vandi; Elena Antelmi; Dimitri Perrin; Samuel T Kuna; Paula K Schweitzer; Clete Kushida; Paul E Peppard; Helge B D Sorensen; Poul Jennum; Emmanuel Mignot
Journal:  Nat Commun       Date:  2018-12-06       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.